Project description
MRI contrast agents may soon be able to treat conditions in addition to diagnosing them
Magnetic resonance imaging (MRI) harnesses the body's natural magnetic properties to produce detailed images of organs and tissues. Although originally intended to be used without contrast agents, research showed that such agents enhance sensitivity and/or selectivity, improving the accuracy of diagnoses in many conditions. There are now many different contrast agents available, largely based on which tissues or structures are of interest. However, increasing evidence suggests some of these may accumulate in tissues with repeated use and a need exists for alternative solutions. NOVA-MRI is harnessing the power of smart nanoparticles and their functionalisation. It could pave the way to novel contrast agents that can carry therapeutics to a target site and facilitate controlled release and treatment.
Fields of science
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
Participants (11)
20009 San Sebastian
Participation ended
08007 Barcelona
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.